Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Bucillamine: Interim Phase IIa data

Interim data from 29 patients with acute gout flares in an open-label, U.S.

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE